Cost-benefit analysis and health care evaluations:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cheltenham u.a.
Elgar
2003
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Includes index |
| Beschreibung: | XXII, 373 S. graph. Darst. |
| ISBN: | 1840648449 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV014668994 | ||
| 003 | DE-604 | ||
| 005 | 20040402 | ||
| 007 | t | ||
| 008 | 020820s2003 xxud||| |||| 00||| eng d | ||
| 010 | |a 2002029830 | ||
| 020 | |a 1840648449 |9 1-84064-844-9 | ||
| 035 | |a (OCoLC)249011311 | ||
| 035 | |a (DE-599)BVBBV014668994 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-384 |a DE-703 |a DE-706 |a DE-521 |a DE-11 | ||
| 050 | 0 | |a RA410.5.B74 2003 | |
| 082 | 0 | |a 362.1/068/5 |2 21 | |
| 082 | 0 | |a 362.1/068/5 21 | |
| 084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
| 100 | 1 | |a Brent, Robert J. |d 1946- |e Verfasser |0 (DE-588)130361062 |4 aut | |
| 245 | 1 | 0 | |a Cost-benefit analysis and health care evaluations |c ed. by Robert J. Brent |
| 246 | 1 | |a Cost benefit analysis and health care evaluations | |
| 264 | 1 | |a Cheltenham u.a. |b Elgar |c 2003 | |
| 300 | |a XXII, 373 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes index | ||
| 650 | 4 | |a Coût-efficacité | |
| 650 | 7 | |a Gezondheidszorg |2 gtt | |
| 650 | 7 | |a Kosten-effectiviteitsanalyse |2 gtt | |
| 650 | 4 | |a Soins médicaux - Coût-efficacité - Recherche - Méthodologie | |
| 650 | 4 | |a Gesundheitswesen | |
| 650 | 4 | |a Medical care -- Cost effectiveness -- Research -- Methodology | |
| 650 | 4 | |a Cost effectiveness | |
| 650 | 0 | 7 | |a Gesundheitswesen |0 (DE-588)4020775-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Medizinische Versorgung |0 (DE-588)4038270-9 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 0 | 1 | |a Gesundheitswesen |0 (DE-588)4020775-4 |D s |
| 689 | 0 | 2 | |a Medizinische Versorgung |0 (DE-588)4038270-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Medizinische Versorgung |0 (DE-588)4038270-9 |D s |
| 689 | 1 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 1 | 2 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |D s |
| 689 | 1 | |8 1\p |5 DE-604 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009952702&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009952702 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804129420834766848 |
|---|---|
| adam_text | Contents
List offigures x
List of tables xi
List of abbreviations xv
Preface xvii
Acknowledgements xix
PART I INTRODUCTION
1 Introduction to health care evaluation 3
1.1 Introduction 3
1.2 Types of economic evaluation 6
1.3 The basics of cost benefit analysis 11
1.4 Applications 14
1.5 Final section 25
PART II CM AND CBA
2 Cost minimization and the definition of cost 31
2.1 Introduction 31
2.2 Cost minimization and economic theory 33
2.3 Cost benefit analysis and cost minimization 41
2.4 Applications 46
2.5 Final section 56
3 Types of costs and their measurement 60
3.1 Introduction 60
3.2 Costs and markets 64
3.3 Costs versus charges 69
3.4 Applications 71
3.5 Final section 81
4 External costs 86
4.1 Introduction 86
4.2 External costs and markets 89
4.3 External costs over time 94
v/7
viii Contents
4.4 Applications 98
4.5 Final section 108
5 Social cost of taxation 112
5.1 Introduction 112
5.2 Economic theory and the MCF 117
5.3 Estimates of the MCF 120
5.4 Applications 122
5.5 Final section 134
PART III CEA AND CBA
6 Fundamentals of cost effectiveness analysis 141
6.1 Introduction 141
6.2 Basic principles of CEA 143
6.3 Methods for converting a CEA into a CBA 149
6.4 Applications 154
6.5 Final section 162
7 Further issues of cost effectiveness analysis 165
7.1 Introduction 165
7.2 Discounting in CEA 166
7.3 Sampling error and uncertainty about estimates 173
7.4 Applications 178
7.5 Final section 188
PART IV CUAANDCBA
8 Fundamentals of cost utility analysis 193
8.1 Introduction 193
8.2 Basic principles of CUA 196
8.3 CUA versus CBA 202
8.4 Applications 204
8.5 Final section 216
9 Measuring Utilities in cost utility analysis 219
9.1 Introduction 219
9.2 Main measurement sources 225
9.3 Main measurement methods 228
9.4 Applications 232
9.5 Final section 242
Contents ix
10 Cost utility analysis and equity 246
10.1 Introduction 246
10.2 DALYs 249
10.3 QALYs and ageism 253
10.4 Thepersontrade off(PTO) 256
10.5 Applications 259
10.6 Final section 266
PART V CBA
11 Cost benefit analysis and the human capital approach 271
11.1 Introduction 271
11.2 Human capital approach 273
11.3 The relation between WTP and human capital 275
11.4 Methods for converting a CUA into a CBA 279
11.5 Applications 283
11.6 Final section 292
12 Cost benefit analysis and willingness to pay 296
12.1 Introduction 296
12.2 Willingness to pay approach 300
12.3 WTP and rationing by time 303
12.4 Applications 309
12.5 Final section 320
13 Cost benefit analysis and equity 323
13.1 Introduction 323
13.2 Distribution weights 328
13.3 Numbers effect 332
13.4 Applications 335
13.5 Final section 346
References 353
Index 365
Figures
2.1 The production function relating length of stay to the number
of nurses 37
2.2 A CBA of a particular intervention 42
2.3 A CM as a CBA 44
2.4 A CEA as a CBA 45
3.1 A competitive market s demand and supply measures MB
and MC 65
3.2 A competitive firm produces at the lowest point of its AC 67
3.3 A monopolist s prices arc greater than MC 68
4.1 Competitive markets produce too little when a negative
externality exists 90
4.2 100% vaccination may not be optimal 93
4.3 When MC falls, the MB = MC rule may fail to be socially
optimal 96
5.1 Modifying the MB = MC rule when taxes exist which cause
aMCF 113
5.2 Calculating the MCF when there are constant costs 117
5.3 Calculating the MCF when demand is perfectly inelastic 119
6.1 Average and incremental cost effectiveness ratios 148
6.2 The exponential function depicting the diminishing marginal
utility of income 156
7.1 Incremental cost effectiveness ratios with sampling variation
in costs and effects 177
11.1 The trade off of lifetime income for survival probabilities 277
11.2 The relation between WTP and lifetime earnings 279
12.1 The relation between WTP and willingness to accept 302
12.2 Demand and supply with waiting time as the price 304
12.3 Benefits as a function of time till treatment 307
12.4 Demand and supply as functions of the full price 311
12.5 Demand, government supply and need 313
x
Tables
1.1 Costs and effects for alternative gallstone treatments 16
1.2 Cost and effect per patient for worksite care and regular care 18
1.3 Comparison of CBA and CEA study reports from 1979
to 1990 21
1.4 Detection rates for successive stool guaiac tests 24
1.5 Evaluation of neo natal intensive care treatment 26
2.1 Short run production function for lengths of stay (LOS) 36
2.2 Short run cost curves for lengths of stay (LOS) 36
2.3 Long run production function for lengths of stay (LOS) 38
2.4 Discount factors for alternative time horizons and interest
rates 40
2.5 Cumulative expected savings per quitter at time of
cessation ( $) 41
2.6 Reference requirements for 5 treatments (per 100 bed days) 47
2.7 Costs per patient for ulcer treatment 49
2.8 Inflation controlled hospital costs for total knee
arthroplasty ( $) 52
2.9 Lifetime costs of HIV (in Australian $) 54
2.10 Costs of different treatments before and after treatment ( $) 57
3.1 Percent of cases where RCC estimated costs are within
10% of RVU estimated costs 71
3.2 Marginal cost of acute inpatient care ( $) 73
3.3 Per visit costs for hospital outpatient care by type of
output ( $) 74
3.4 DRGs that give different profitability outcomes using
RVUs and RCCs 75
3.5 Resource based relative values and Medicare charges 78
3.6 Estimates of the share of the physician s bill that counts
as costs 81
3.7 Hypothetical translation of a patient s bill: charges to costs 82
3.8 Hypothetical use of cost centers ( $) 83
4.1 Consequences of increased taxes in consumer surplus loss
to drinkers and lives saved 99
4.2 Literature estimates of costs and benefits on a comparable
basis 102
xi
xii Tables
4.3 Comparison of optimal and actual policies 104
4.4 Internal rates of return on polio research under a variety of
assumptions 107
4.5 Sensitivity analysis for JE vaccination program in
Thailand 108
5.1 Estimates of the marginal cost of funds for the US federal
government (MCFp) 121
5.2 Estimates of the marginal cost of funds for US state
governments (MCFS) 123
5.3 Net benefits of a permanent $1 increase in social security
(1985 2060) 126
5.4 The data on prices, quantities and costs for non federal
general hospitals (1990) 128
5.5 Net benefits of privatization of non federal general
hospitals in the US 129
5.6 Weighted costs of systems of psychiatric care in
Massachusetts 131
5.7 Evaluation of case management programs 134
5.8 The relation between the excess burden and the level of
the tax rate 135
6.1 Hypothetical example of the cost effectiveness paradigm 144
6.2 Hypothetical example of the cost effectiveness paradigm
with competing choices 145
6.3 Cost and effect per patient for worksite care and regular
care 147
6.4 Total costs and results of the alternative strategies to
diagnose deep vein thrombosis 155
6.5 Optimal spending and CE ratio: men, income = 000 157
6.6 Federal evaluation of state psychiatric hospital care 159
6.7 Determinants of decisions concerning alcohol treatment
effectiveness 161
6.8 Effects and costs of screening for cervical cancer using the
Pap smear 163
7.1 Programs with varying timing of costs and benefits 170
7.2 Programs with a delayed timing of costs and effects 171
7.3 Programs with costs that vary by individuals 174
7.4 Wage equation estimates 179
7.5 Estimates of social discount rates for the period 1965 89 (%) 181
7.6 Estimates and 95% lower and upper confidence limits for
EIC in the SRTI trial 185
7.7 Confidence intervals (CI) for incremental cost effectiveness
ratios, ICD vs EP 187
Tables xiii
8.1 Comparative cost utility results for selected programs 195
8.2 Calculations of QWB with and without treatment 199
8.3 Top 10 priorities of the Oregon HSC initially and
subsequently 200
8.4 Measures of economic evaluation of neo natal intensive
care by birth weight 205
8.5 Some extracts of cost for QALYs for competing
treatments 208
8.6 Balance sheet of expected effect of demonstration program
on number of people covered, services covered and
financial costs 211
8.7 Cost effectiveness ratio estimates of THA and other
procedures 214
9.1 Utility values using TTO for patients versus general public
by duration 220
9.2 Mean time trade off and visual analogue scores 222
9.3 Intra class correlation using time trade off 224
9.4 The Rosser and Kind index of health status 227
9.5 Selected results from comparative valuation studies 233
9.6 Mean SG, TTO and RS quality weights for health state E 235
9.7 The seven health profiles included in the experiment 236
9.8 Implied rankings of the seven health profiles for different
quality weights 236
9.9 Mean Spearman rank correlation coefficients between the
direct rankings and the predicted rankings of RS, TTO
and SG 237
9.10 Results for visual function and utility values according to
visual acuity 239
9.11 Patients willing to trade time for improved vision (TTO
method) and risk immediate death for improved vision
(SG method) 240
9.12 Ratings of standardized health states 241
10.1 Revised disability classes for the Global Burden Disease
Study based on the results of the PTO protocol used at the
Geneva meeting on disability weight 251
10.2 DALY losses by age at death in Uganda 252
10.3 Comparison of DALYs versus deaths in demographically
developing countries by categories of disease 252
10.4 Comparison of DALYs versus deaths by income grouping 253
10.5 Life expectancies at birth and after intervention (remaining
years) 254
10.6 Utilities for health states with knee condition 259
xiv Tables
10.7 The number of lives, life years and QALYs saved among
50 year olds and 70 year olds equivalent to saving one life,
life year and QALY among 30 year olds 261
10.8 Incremental cost effectiveness analysis for sleeping sickness
in Uganda 263
10.9 Apparent impact of HIV on mortality: DALYs as
compared with HeaLYs, 1990 265
11.1 The value of a quality adjusted life year (1997 dollars) by
study type 282
11.2 Costs of syphilis prevention (in millions of dollars, except
for cost per case) 284
11.3 Costs and benefits of alternative mental health programs 287
11.4 Costs and benefits of the 55 mph speed limit decision using
different numeraires 291
12.1 Estimated value of waiting list time (£ per month) 305
12.2 Monetary valuations of NHS nursing home care and
hospital care for respondents with a preference for NHS
nursing home care (n = 83) 317
12.3 Conjoint analysis results for the choice of medication
versus surgery for the management of miscarriage 319
13.1 Price elasticities for health in Peru by income quintile 329
13.2 Weighted net benefits of case management programs with
alternative sets of distribution weights ( $) 338
13.3 Number responding and stated willingness to pay as
percent of family income 339
13.4 Equivalence numbers in questionnaires without and with
explicit arguments 341
13.5 Numbers weights for severity of illness corresponding to
PTO estimates 342
13.6 Aggregate results: percentage change in total demand
accounted for by each income quintile and consumers
welfare loss as a percentage of income by income quintile 344
13.7 Disaggregated results for quantity reductions (D/D) by
quintile 344
13.8 Disaggregated results for benefit losses as a percentage of
income (B/Y;) by quintile 345
13.9 Disaggregated costs and benefits of raising user fees in Peru
by quintile 347
|
| any_adam_object | 1 |
| author | Brent, Robert J. 1946- |
| author_GND | (DE-588)130361062 |
| author_facet | Brent, Robert J. 1946- |
| author_role | aut |
| author_sort | Brent, Robert J. 1946- |
| author_variant | r j b rj rjb |
| building | Verbundindex |
| bvnumber | BV014668994 |
| callnumber-first | R - Medicine |
| callnumber-label | RA410 |
| callnumber-raw | RA410.5.B74 2003 |
| callnumber-search | RA410.5.B74 2003 |
| callnumber-sort | RA 3410.5 B74 42003 |
| callnumber-subject | RA - Public Medicine |
| classification_rvk | QX 700 |
| ctrlnum | (OCoLC)249011311 (DE-599)BVBBV014668994 |
| dewey-full | 362.1/068/5 362.1/068/521 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.1/068/5 362.1/068/5 21 |
| dewey-search | 362.1/068/5 362.1/068/5 21 |
| dewey-sort | 3362.1 268 15 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02445nam a2200601zc 4500</leader><controlfield tag="001">BV014668994</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20040402 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020820s2003 xxud||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2002029830</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1840648449</subfield><subfield code="9">1-84064-844-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)249011311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014668994</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA410.5.B74 2003</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.1/068/5</subfield><subfield code="2">21</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.1/068/5 21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brent, Robert J.</subfield><subfield code="d">1946-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130361062</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cost-benefit analysis and health care evaluations</subfield><subfield code="c">ed. by Robert J. Brent</subfield></datafield><datafield tag="246" ind1="1" ind2=" "><subfield code="a">Cost benefit analysis and health care evaluations</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cheltenham u.a.</subfield><subfield code="b">Elgar</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 373 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Coût-efficacité</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gezondheidszorg</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kosten-effectiviteitsanalyse</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Soins médicaux - Coût-efficacité - Recherche - Méthodologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gesundheitswesen</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care -- Cost effectiveness -- Research -- Methodology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cost effectiveness</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009952702&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009952702</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV014668994 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:04:52Z |
| institution | BVB |
| isbn | 1840648449 |
| language | English |
| lccn | 2002029830 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009952702 |
| oclc_num | 249011311 |
| open_access_boolean | |
| owner | DE-384 DE-703 DE-706 DE-521 DE-11 |
| owner_facet | DE-384 DE-703 DE-706 DE-521 DE-11 |
| physical | XXII, 373 S. graph. Darst. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | Elgar |
| record_format | marc |
| spelling | Brent, Robert J. 1946- Verfasser (DE-588)130361062 aut Cost-benefit analysis and health care evaluations ed. by Robert J. Brent Cost benefit analysis and health care evaluations Cheltenham u.a. Elgar 2003 XXII, 373 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Includes index Coût-efficacité Gezondheidszorg gtt Kosten-effectiviteitsanalyse gtt Soins médicaux - Coût-efficacité - Recherche - Méthodologie Gesundheitswesen Medical care -- Cost effectiveness -- Research -- Methodology Cost effectiveness Gesundheitswesen (DE-588)4020775-4 gnd rswk-swf Gesundheitsökonomie (DE-588)4130935-2 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Medizinische Versorgung (DE-588)4038270-9 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 s Gesundheitswesen (DE-588)4020775-4 s Medizinische Versorgung (DE-588)4038270-9 s DE-604 Gesundheitsökonomie (DE-588)4130935-2 s 1\p DE-604 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009952702&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Brent, Robert J. 1946- Cost-benefit analysis and health care evaluations Coût-efficacité Gezondheidszorg gtt Kosten-effectiviteitsanalyse gtt Soins médicaux - Coût-efficacité - Recherche - Méthodologie Gesundheitswesen Medical care -- Cost effectiveness -- Research -- Methodology Cost effectiveness Gesundheitswesen (DE-588)4020775-4 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Medizinische Versorgung (DE-588)4038270-9 gnd |
| subject_GND | (DE-588)4020775-4 (DE-588)4130935-2 (DE-588)4032589-1 (DE-588)4038270-9 |
| title | Cost-benefit analysis and health care evaluations |
| title_alt | Cost benefit analysis and health care evaluations |
| title_auth | Cost-benefit analysis and health care evaluations |
| title_exact_search | Cost-benefit analysis and health care evaluations |
| title_full | Cost-benefit analysis and health care evaluations ed. by Robert J. Brent |
| title_fullStr | Cost-benefit analysis and health care evaluations ed. by Robert J. Brent |
| title_full_unstemmed | Cost-benefit analysis and health care evaluations ed. by Robert J. Brent |
| title_short | Cost-benefit analysis and health care evaluations |
| title_sort | cost benefit analysis and health care evaluations |
| topic | Coût-efficacité Gezondheidszorg gtt Kosten-effectiviteitsanalyse gtt Soins médicaux - Coût-efficacité - Recherche - Méthodologie Gesundheitswesen Medical care -- Cost effectiveness -- Research -- Methodology Cost effectiveness Gesundheitswesen (DE-588)4020775-4 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Medizinische Versorgung (DE-588)4038270-9 gnd |
| topic_facet | Coût-efficacité Gezondheidszorg Kosten-effectiviteitsanalyse Soins médicaux - Coût-efficacité - Recherche - Méthodologie Gesundheitswesen Medical care -- Cost effectiveness -- Research -- Methodology Cost effectiveness Gesundheitsökonomie Kosten-Nutzen-Analyse Medizinische Versorgung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009952702&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT brentrobertj costbenefitanalysisandhealthcareevaluations |